Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo

Nature volume 323, pages 276–278 (1986)Cite this article

Abstract

Among the eleven drugs or chemicals which are well-documented human teratogens, eight (or their main metabolites) are weak acids whereas none is a weak base. Moreover, 23 out of 32 acids tested have been found to be teratogenic in at least one animal species1. The acidic property of drugs may therefore be an important determinant of teratogenicity. We demonstrate here that the intracellular pH (pHi) of the mouse and rat embryo is higher than that of maternal plasma, as determined by the relative accumulation of dimethadione. The antiepileptic drug valproic acid and its pharmacologically active unsaturated metabolite accumulate in embryonic tissue to higher concentrations than in maternal plasma, whereas the essentially neutral amide of valproic acid (valpromide) or ethosuximide do not accumulate in the embryo; we further demonstrate in the rat that the pHi; of the embryo decreases with advancing gestation; in general agreement with the pH partition hypothesis, the exposure of the embryo to valproic acid also decreases significantly during that period. Furthermore, the amides of two weak acid teratogens, valpromide and methoxyacetamide, and the imide ethosuximide, are much less teratogenic than their acid counterparts. Our results suggest that weakly acidic drugs, by virtue of their physico-chemical nature, accumulate in the early embryo with its relatively high pHi.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Freese, E. et al. Teratology 20, 413–440 (1979).

    CAS  Article  Google Scholar 

  2. Waddell, W. & Butler, T. J. clin. Invest. 38, 720–729 (1959).

    CAS  Article  Google Scholar 

  3. Robert, E. & Rosa, F. Lancet ii, 1142 (1983).

    Article  Google Scholar 

  4. Koch, S., Jäger-Roman, E., Rating, D. & Helge, H. J. Pediat. 103, 1007 (1983).

    CAS  Article  Google Scholar 

  5. Nau, H., Zierer, R., Spielmann, H., Neubert, D. & Gansau, Ch. Life Sci. 29, 2803–2814 (1981).

    CAS  Article  Google Scholar 

  6. Kao, J., Brown, N. A., Schmid, B., Goulding, E. H. & Fabro, S. Teratogen., Carcinogen., Mutagen. 1, 367–382 (1981).

    CAS  Article  Google Scholar 

  7. Ong, L. L. et al. Fundamental appl. Tox. 3, 121–126 (1983).

    CAS  Article  Google Scholar 

  8. Nau, H. et al. J. chromat. 226, 69–78 (1981).

    CAS  Article  Google Scholar 

  9. Brown, N., Holt, D. & Webb, M. Tox. Lett. 22, 93–100 (1984).

    CAS  Article  Google Scholar 

  10. Ritter, E. J., Scott, W. J., Randall, J. L. & Ritter, J. M. Teratology 32, 25–31 (1985).

    CAS  Article  Google Scholar 

  11. Keberle, H., Loustalot, P., Maller, R. K., Faigle, J. W. & Schmid, K. Ann. N.Y. Acad. Sci. 123, 253–265 (1965).

    ADS  Article  Google Scholar 

  12. Danielsson, B. R. G., Ghantous, H. & Dencker, L. Acta pharmac. tox. 55, 410–417 (1984).

    CAS  Article  Google Scholar 

  13. Tagashira, E. et al. Japan J. pharmac. 31, 563–571 (1981).

    CAS  Article  Google Scholar 

  14. Willhite, C. & Shealy, F. J. natn. Cancer Inst. 72, 689–694 (1984).

    CAS  Google Scholar 

  15. Löscher, W. & Nau, H. Neuropharmacology 24, 427–435 (1985).

    Article  Google Scholar 

  16. Sullivan, F. M. & McElhatton, P. Tox. appl Pharmacol. 40, 365–378 (1977).

    CAS  Article  Google Scholar 

  17. Fabro, S., Shull, G. & Brown, N. A. Teratogen., Carcinogen., Mutagen. 2, 61–76 (1982).

    CAS  Article  Google Scholar 

  18. Nau, H., Löscher, W. & Schäfer, H. Neurology 34, 400–401 (1984).

    CAS  Article  Google Scholar 

  19. Helm, F.-Ch., Frankus, E., Fridereichs, E., Graudums, I. & Flohe, L. Arzneimittel.-Forsch., 31, 941–949 (1981).

    CAS  Google Scholar 

  20. Nau, H. & Löscher, W. Fundamental appl. Tox. 6, 669–676 (1986).

    CAS  Article  Google Scholar 

  21. Mirkin, B. L. & Singh, S. in Perinatal Pharmacology and Therapeutics (ed. Mirkin, B. L.) 1–69 (Academic, New York, 1986).

    Google Scholar 

  22. Mast, T. J., Cukierski, M. A., Nau, H. & Hendrickx, A. G. Toxicology 39, 111–119 (1986).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Institut für Toxikologie und Embryonalpharmokologie, Freie Universität Berlin, Garystrasse 5, D-1000, Berlin, 33, FRG

    Heinz Nau

  2. Division of Basic Science Research, Children's Hospital Research Foundation, Elland and Bethesda Aves, Cincinnati, Ohio, 45229, USA

    William J. Scott Jr

Authors
  1. Heinz Nau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William J. Scott Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nau, H., Scott, W. Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature 323, 276–278 (1986). https://doi.org/10.1038/323276a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/323276a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing